Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formulating and Validating Nursing Diagnosis II01:25

Formulating and Validating Nursing Diagnosis II

Nursing diagnoses represent a problem validated by major defining characteristics. There are four categories of nursing diagnoses: problem-focused, risk, health promotion or wellness, and syndrome. The anatomy of a nursing diagnosis includes three components: problem statement or diagnostic label, defining characteristics, and related factors.
Risk nursing diagnoses represent clinical judgments of an individual, family, or community more vulnerable to developing the health problem than others...
Nursing Diagnosis01:22

Nursing Diagnosis

Following assessment, a nursing diagnosis is the next step in the nursing process. It begins after the nurse has collected and recorded the patient data. The purpose of diagnosing is to identify how the client responds to actual or potential health processes, identify factors that bestow or that cause health problems, the etiologies, and identify resources or strengths the individual, group, or community can draw on to prevent or resolve problems.
The nursing diagnosis focuses on evidence-based...
Documentation of Nursing Diagnosis01:10

Documentation of Nursing Diagnosis

The nurse documents nursing diagnoses and enters them into the patient record. The identified patient's nursing diagnosis is either written out with a plan of care or entered into the electronic health record.
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters assessment...
Formulating and Validating Nursing Diagnosis I01:26

Formulating and Validating Nursing Diagnosis I

A nursing diagnosis is written when the nurse recognizes a cluster of essential patient data indicating health problems treated with independent nursing interventions. The standardized terminologies of a nursing diagnosis help nurses identify and treat patients' problems. Every electronic health record that uses nursing diagnosis must employ standard diagnostic terminology. Developing an efficient, individualized care plan begins with accurate nursing diagnoses.
There are thirteen domains for...
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De novo EHMT2 variants cause an autosomal dominant EHMT2-related Kleefstra syndrome via loss of G9a methyltransferase activity.

Nature communications·2026
Same author

Autosomal Dominant Tubulointerstitial Kidney Disease: My Kingdom for a Biomarker.

Journal of the American Society of Nephrology : JASN·2026
Same author

Thin Glomerular Basement Membrane Phenotypes With No Identified Pathogenic <i>COL4A3/A4/A5</i> Variant.

Kidney international reports·2026
Same author

Autosomal Dominant Tubulointerstitial Kidney Disease: Approach to Diagnosis.

Advances in kidney disease and health·2026
Same author

Correction to: Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM).

Kidney360·2026
Same author

Autosomal Dominant Tubulointerstitial Kidney Disease Clinical Trial Simulator: Case Reports of Model-Informed Drug Development.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Fabry Disease: Current Perspectives on Diagnosis and Management Strategies.

Advances in kidney disease and health·2026
Same journal

Collagen Genes-Related Glomerular Disease.

Advances in kidney disease and health·2026
Same journal

Genetic Nephrotic Syndrome in Children and Adolescents: An Update.

Advances in kidney disease and health·2026
Same journal

Incorporating Genetics Into Nephrology Practice-The New National Kidney Foundation Guidelines for Genetic Testing.

Advances in kidney disease and health·2026
Same journal

Genetic and Clinical Evaluation of Pediatric Cystic Kidney Diseases: Autosomal Dominant and Autosomal Recessive Polycystic Kidney Disease.

Advances in kidney disease and health·2026
Same journal

Autosomal Dominant Polycystic Kidney Disease: Genetic Insights, Phenotypic Spectrum, and Advances in Prognosis and Treatment.

Advances in kidney disease and health·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

After the Diagnosis.

Anthony J Bleyer1, Stanislav Kmoch1

  • 1Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC; Research Unit of Rare Diseases, Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.

Advances in Kidney Disease and Health
|June 22, 2026
PubMed
Summary
This summary is machine-generated.

Diagnosing a rare genetic disease starts a journey for patients and researchers. Patient involvement in research is crucial for understanding the condition and finding effective treatments.

Keywords:
Autosomal dominant tubulointerstitial kidney diseaseKidneyPatient foundationsRare diseaseRare disease research

More Related Videos

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

Related Experiment Videos

Last Updated: Jun 24, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

Area of Science:

  • Medical Genetics
  • Rare Diseases
  • Patient Advocacy

Background:

  • Diagnosis of rare genetic diseases presents unique challenges for patients and clinicians.
  • Limited information and prior research often accompany rare conditions, making each new case vital.
  • Patient foundations and dedicated researchers play a key role in advancing understanding and treatment.

Purpose of the Study:

  • To outline the critical role of patient participation in rare disease research.
  • To emphasize the collaborative efforts between clinicians, patients, and researchers in driving therapeutic progress.
  • To highlight how patient-provided data contributes to disease characterization and treatment development.

Main Methods:

  • Leveraging case reports and clinical information from newly diagnosed patients.
  • Facilitating patient engagement with foundations and research opportunities.
  • Analyzing patient-contributed clinical, genetic, and biological data.

Main Results:

  • Each patient's contribution is essential for building knowledge about rare genetic diseases.
  • Collaborative efforts between patients and researchers accelerate research progress.
  • Increased patient participation leads to better disease characterization and potential treatments.

Conclusions:

  • The journey from diagnosis to treatment for rare genetic diseases relies heavily on patient involvement and collaboration.
  • Clinicians are pivotal in guiding patients toward resources and research participation.
  • A multidisciplinary approach involving patients, clinicians, and researchers is critical for developing therapies for rare conditions.